5-(3,4-difluorophenyl)-3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole

ID: ALA519811

PubChem CID: 12002524

Max Phase: Preclinical

Molecular Formula: C13H10F2N6

Molecular Weight: 288.26

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1ccc(C2Cc3[nH]nc(-c4nnn[nH]4)c3C2)cc1F

Standard InChI:  InChI=1S/C13H10F2N6/c14-9-2-1-6(4-10(9)15)7-3-8-11(5-7)16-17-12(8)13-18-20-21-19-13/h1-2,4,7H,3,5H2,(H,16,17)(H,18,19,20,21)

Standard InChI Key:  MHSDQXXJYZLCMS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 24  0  0  0  0  0  0  0  0999 V2000
   14.9368   -6.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4069   -6.7401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4366   -5.4054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2153   -5.6776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1962   -6.4997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9721   -6.7720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4709   -6.1182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0031   -5.4419    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2086   -7.5624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7082   -8.2170    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1775   -8.8956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9679   -8.6591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9872   -7.8342    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1119   -6.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7206   -5.3181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8965   -5.2994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4673   -6.0051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8681   -6.7310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6910   -6.7462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4423   -7.4378    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.6424   -5.9878    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  5  1  0
  4  3  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  3  1  1  0
  1 14  1  0
  5  6  1  0
 14 15  2  0
  6  7  2  0
 15 16  1  0
  7  8  1  0
 16 17  2  0
  8  4  1  0
 17 18  1  0
  4  5  2  0
 18 19  2  0
 19 14  1  0
  6  9  1  0
 18 20  1  0
  9 10  1  0
 17 21  1  0
M  END

Associated Targets(Human)

HCAR2 Tclin Hydroxycarboxylic acid receptor 2 (1903 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hcar2 Hydroxycarboxylic acid receptor 2 (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.26Molecular Weight (Monoisotopic): 288.0935AlogP: 1.75#Rotatable Bonds: 2
Polar Surface Area: 83.14Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.38CX Basic pKa: 1.27CX LogP: 2.42CX LogD: 0.81
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.75Np Likeness Score: -1.75

References

1. Imbriglio JE, Chang S, Liang R, Raghavan S, Schmidt D, Smenton A, Tria S, Schrader TO, Jung JK, Esser C, Taggart AK, Cheng K, Carballo-Jane E, Gerard Waters M, Tata JR, Colletti SL..  (2009)  GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.,  19  (8): [PMID:19307116] [10.1016/j.bmcl.2009.03.014]

Source